Active mutants of the TCR-mediated p38α alternative activation site show changes in the phosphorylation lip and DEF site formation

Journal of Molecular Biology

Volumn 405, Issue 5, 2011, Pages 1154-1169

  Tzarum, Netanel ^a   Diskin, Ron ^a   Engelberg, David ^a   Livnah, Oded ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

alternative activation; MAP kinase; p38 ; signaling; T cells

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 14; T LYMPHOCYTE RECEPTOR;

ARTICLE; CONTROLLED STUDY; CRYSTALLOGRAPHY; ENZYME ACTIVATION; GENE MUTATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PHOSPHORYLATION; SITE DIRECTED MUTAGENESIS;

EID: 78751578955     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2010.11.023     Document Type: Article

References (61)

1. Widmann C., Gibson S., Jarpe M.B., and Johnson G.L. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human Physiol. Rev. 79 1999 143 180
2. Jiang Y., Gram H., Zhao M., New L., Gu J., and Feng L. Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38delta J. Biol. Chem. 272 1997 30122 30128
3. Enslen H., Brancho D.M., and Davis R.J. Molecular determinants that mediate selective activation of p38 MAP kinase isoforms EMBO J. 19 2000 1301 1311
4. Wang X.S., Diener K., Manthey C.L., Wang S., Rosenzweig B., and Bray J. Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase J. Biol. Chem. 272 1997 23668 23674
5. Eckert R.L., Efimova T., Balasubramanian S., Crish J.F., Bone F., and Dashti S. p38 mitogen-activated protein kinases on the body surface-a function for p38 delta J. Invest. Dermatol. 120 2003 823 828
6. Hu M.C., Wang Y.P., Mikhail A., Qiu W.R., and Tan T.H. Murine p38-delta mitogen-activated protein kinase, a developmentally regulated protein kinase that is activated by stress and proinflammatory cytokines J. Biol. Chem. 274 1999 7095 7102
7. Shi Y., and Gaestel M. In the cellular garden of forking paths: how p38 MAPKs signal for downstream assistance Biol. Chem. 383 2002 1519 1536
8. Lee J.C., Laydon J.T., McDonnell P.C., Gallagher T.F., Kumar S., and Green D. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis Nature 372 1994 739 746
9. Han J., Lee J.D., Bibbs L., and Ulevitch R.J. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells Science 265 1994 808 811
10. Haq R., and Zanke B. Inhibition of apoptotic signaling pathways in cancer cells as a mechanism of chemotherapy resistance Cancer Metastasis Rev. 17 1998 233 239
11. Harkin D.P., Bean J.M., Miklos D., Song Y.H., Truong V.B., and Englert C. Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1 Cell 97 1999 575 586
12. Recio J.A., and Merlino G. Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1 Oncogene 21 2002 1000 1008
13. Lee J.C., Kumar S., Griswold D.E., Underwood D.C., Votta B.J., and Adams J.L. Inhibition of p38 MAP kinase as a therapeutic strategy Immunopharmacology 47 2000 185 201
14. English J.M., and Cobb M.H. Pharmacological inhibitors of MAPK pathways Trends Pharmacol. Sci. 23 2002 40 45
15. Jackson P.F., and Bullington J.L. Pyridinylimidazole based p38 MAP kinase inhibitors Curr. Top. Med. Chem. 2 2002 1011 1020
16. Kumar S., Boehm J., and Lee J.C. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases Nat. Rev., Drug Discov. 2 2003 717 726
17. Clerk A., Michael A., and Sugden P.H. Stimulation of multiple mitogen-activated protein kinase sub-families by oxidative stress and phosphorylation of the small heat shock protein, HSP25/27, in neonatal ventricular myocytes Biochem. J. 333 1998 581 589
18. Hazzalin C.A., Cano E., Cuenda A., Barratt M.J., Cohen P., and Mahadevan L.C. p38/RK is essential for stress-induced nuclear responses: JNK/SAPKs and c-Jun/ATF-2 phosphorylation are insufficient Curr. Biol. 6 1996 1028 1031
19. Ono K., and Han J. The p38 signal transduction pathway: activation and function Cell Signalling 12 2000 1 13
20. Pugazhenthi S., Boras T., O'Connor D., Meintzer M.K., Heidenreich K.A., and Reusch J.E. Insulin-like growth factor I-mediated activation of the transcription factor cAMP response element-binding protein in PC12 cells. Involvement of p38 mitogen-activated protein kinase-mediated pathway J. Biol. Chem. 274 1999 2829 2837
21. Xing J., Kornhauser J.M., Xia Z., Thiele E.A., and Greenberg M.E. Nerve growth factor activates extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways to stimulate CREB serine 133 phosphorylation Mol. Cell. Biol. 18 1998 1946 1955
22. Kyriakis J.M., and Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation Physiol. Rev. 81 2001 807 869
23. DeLano W.L. The PyMOL Molecular Graphics System 2002 DeLano Scientific San Carlos, CA
24. Zarubin T., and Han J. Activation and signaling of the p38 MAP kinase pathway Cell Res. 15 2005 11 18
25. Ge B., Gram H., Di Padova F., Huang B., New L., and Ulevitch R.J. MAPKK-independent activation of p38alpha mediated by TAB1-dependent autophosphorylation of p38alpha Science 295 2002 1291 1294
26. Gills J.J., Castillo S.S., Zhang C., Petukhov P.A., Memmott R.M., and Hollingshead M. Phosphatidylinositol ether lipid analogues that inhibit AKT also independently activate the stress kinase, p38alpha, through MKK3/6-independent and -dependent mechanisms J. Biol. Chem. 282 2007 27020 27029
27. Salvador J.M., Mittelstadt P.R., Guszczynski T., Copeland T.D., Yamaguchi H., and Appella E. Alternative p38 activation pathway mediated by T cell receptor-proximal tyrosine kinases Nat. Immunol. 6 2005 390 395
28. Mittelstadt P.R., Yamaguchi H., Appella E., and Ashwell J.D. T cell receptor-mediated activation of p38α by mono-phosphorylation of the activation loop results in altered substrate specificity J. Biol. Chem. 284 2009 15469 15474
29. Jirmanova L., Sarma D.N., Jankovic D., Mittelstadt P.R., and Ashwell J.D. Genetic disruption of p38alpha Tyr323 phosphorylation prevents T-cell receptor-mediated p38alpha activation and impairs interferon-gamma production Blood 113 2009 2229 2237
30. Wilson K.P., Fitzgibbon M.J., Caron P.R., Griffith J.P., Chen W., and McCaffrey P.G. Crystal structure of p38 mitogen-activated protein kinase J. Biol. Chem. 271 1996 27696 27700
31. Zhang F., Strand A., Robbins D., Cobb M.H., and Goldsmith E.J. Atomic structure of the MAP kinase ERK2 at 2.3 Å resolution Nature 367 1994 704 711
32. Lee T., Hoofnagle A.N., Kabuyama Y., Stroud J., Min X., and Goldsmith E.J. Docking motif interactions in MAP kinases revealed by hydrogen exchange mass spectrometry Mol. Cell 14 2004 43 55
33. Tanoue T., Adachi M., Moriguchi T., and Nishida E. A conserved docking motif in MAP kinases common to substrates, activators and regulators Nat. Cell Biol. 2 2000 110 116
34. Chang C.I., Xu B.E., Akella R., Cobb M.H., and Goldsmith E.J. Crystal structures of MAP kinase p38 complexed to the docking sites on its nuclear substrate MEF2A and activator MKK3b Mol. Cell 9 2002 1241 1249
35. Galanis A., Yang S.H., and Sharrocks A.D. Selective targeting of MAPKs to the ETS domain transcription factor SAP-1 J. Biol. Chem. 276 2001 965 973
36. Sheridan D.L., Kong Y., Parker S.A., Dalby K.N., and Turk B.E. Substrate discrimination among mitogen-activated protein kinases through distinct docking sequence motifs J. Biol. Chem. 283 2008 19511 19520
37. Canagarajah B.J., Khokhlatchev A., Cobb M.H., and Goldsmith E.J. Activation mechanism of the MAP kinase ERK2 by dual phosphorylation Cell 90 1997 859 869
38. Bell M., Capone R., Pashtan I., Levitzki A., and Engelberg D. Isolation of hyperactive mutants of the MAPK p38/Hog1 that are independent of MAPK kinase activation J. Biol. Chem. 276 2001 25351 25358
39. Avitzour M., Diskin R., Raboy B., Askari N., Engelberg D., and Livnah O. Intrinsically active variants of all human p38 isoforms FEBS J. 274 2007 963 975
40. Diskin R., Askari N., Capone R., Engelberg D., and Livnah O. Active mutants of the human p38alpha mitogen-activated protein kinase J. Biol. Chem. 279 2004 47040 47049
41. Diskin R., Engelberg D., and Livnah O. High-resolution diffracting crystals of intrinsically active p38alpha MAP kinase: a case study for low-throughput approaches Acta Crystallogr., Sect. D: Biol. Crystallogr. 63 2007 260 265
42. Askari N., Beenstock J., Livnah O., and Engelberg D. p38alpha is active in vitro and in vivo when monophosphorylated at threonine 180 Biochemistry 48 2009 2497 2504
43. Huse M., and Kuriyan J. The conformational plasticity of protein kinases Cell 109 2002 275 282
44. Taylor S.J., and Shalloway D. An RNA-binding protein associated with Src through its SH2 and SH3 domains in mitosis Nature 368 1994 867 871
45. Zhang Y.Y., Mei Z.Q., Wu J.W., and Wang Z.X. Enzymatic activity and substrate specificity of mitogen-activated protein kinase p38alpha in different phosphorylation states J. Biol. Chem. 283 2008 26591 26601
46. Diskin R., Lebendiker M., Engelberg D., and Livnah O. Structures of p38alpha active mutants reveal conformational changes in L16 loop that induce autophosphorylation and activation J. Mol. Biol. 365 2007 66 76
47. Bellon S., Fitzgibbon M.J., Fox T., Hsiao H.M., and Wilson K.P. The structure of phosphorylated p38gamma is monomeric and reveals a conserved activation-loop conformation Structure 7 1999 1057 1065
48. Zhou T., Sun L., Humphreys J., and Goldsmith E.J. Docking interactions induce exposure of activation loop in the MAP kinase ERK2 Structure 14 2006 1011 1019
49. Jacobs D., Glossip D., Xing H., Muslin A.J., and Kornfeld K. Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase Genes Dev. 13 1999 163 175
50. Murphy L.O., Smith S., Chen R.H., Fingar D.C., and Blenis J. Molecular interpretation of ERK signal duration by immediate early gene products Nat. Cell Biol. 4 2002 556 564
51. Murphy L.O., MacKeigan J.P., and Blenis J. A network of immediate early gene products propagates subtle differences in mitogen-activated protein kinase signal amplitude and duration Mol. Cell. Biol. 24 2004 144 153
52. Vinciguerra M., Vivacqua A., Fasanella G., Gallo A., Cuozzo C., and Morano A. Differential phosphorylation of c-Jun and JunD in response to the epidermal growth factor is determined by the structure of MAPK targeting sequences J. Biol. Chem. 279 2004 9634 9641
53. Cowley S., Paterson H., Kemp P., and Marshall C.J. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells Cell 77 1994 841 852
54. Dean A.M., Lee M.H., and Koshland D.E. Jr Phosphorylation inactivates Escherichia coli isocitrate dehydrogenase by preventing isocitrate binding J. Biol. Chem. 264 1989 20482 20486
55. Stura E.A., Chen P., Wilmot C.M., Arevalo J.H., and Wilson I.A. Crystallization studies of glycosylated and unglycosylated human recombinant interleukin-2 Proteins 12 1992 24 30
56. Otwinowski Z., and Minor W. Processing of X-ray diffraction data collected in oscillation mode Methods Enzymol. 276 1997 307 326
57. Vagin A.A., and Isupov M.N. Spherically averaged phased translation function and its application to the search for molecules and fragments in electron-density maps Acta Crystallogr., Sect. D: Biol. Crystallogr. 57 2001 1451 1456
58. Murshudov G.N., Vagin A.A., and Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method Acta Crystallogr., Sect. D: Biol. Crystallogr. 53 1997 240 255
59. Adams P.D., Afonine P.V., Bunkoczi G., Chen V.B., Davis I.W., and Echols N. PHENIX: a comprehensive Python-based system for macromolecular structure solution Acta Crystallogr., Sect. D: Biol. Crystallogr. 66 2010 213 221
60. Morris R.J., Perrakis A., and Lamzin V.S. ARP/wARP and automatic interpretation of protein electron density maps Methods Enzymol. 374 2003 229 244
61. Emsley P., and Cowtan K. Coot: model-building tools for molecular graphics Acta Crystallogr., Sect. D: Biol. Crystallogr. 60 2004 2126 2132